Clinical Trial Update: A Two-arm (Phase 2) Exploratory Study of Nivolumab Monotherapy or in Combination With Nab-paclitaxel and Carboplatin in Early Stage NSCLC in China [Phase 2]

View source ↗

Summary

A Phase 2 two-arm exploratory trial evaluating nivolumab alone or combined with nab-paclitaxel and carboplatin in early-stage non-small cell lung cancer in Chin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Nab-paclitaxel (paclitaxel protein-bound)
• nivolumab (nivolumab)

Snippet

Sponsor: Guangdong Association of Clinical Trials | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: UNKNOWN